Literature DB >> 23508172

Target validation using chemical probes.

Mark E Bunnage1, Eugene L Piatnitski Chekler, Lyn H Jones.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23508172     DOI： 10.1038/nchembio.1197

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN： 1552-4450            Impact factor:   15.040


× No keyword cloud information.
  30 in total

1.  Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival.

Authors:  Paul Morgan; Piet H Van Der Graaf; John Arrowsmith; Doug E Feltner; Kira S Drummond; Craig D Wegner; Steve D A Street
Journal:  Drug Discov Today       Date:  2011-12-29       Impact factor: 7.851

2.  Designing zebrafish chemical screens.

Authors:  Randall T Peterson; Mark C Fishman
Journal:  Methods Cell Biol       Date:  2011       Impact factor: 1.441

3.  A clickable inhibitor reveals context-dependent autoactivation of p90 RSK.

Authors:  Michael S Cohen; Haralambos Hadjivassiliou; Jack Taunton
Journal:  Nat Chem Biol       Date:  2007-01-28       Impact factor: 15.040

4.  Recognizing and exploiting differences between RNAi and small-molecule inhibitors.

Authors:  William A Weiss; Stephen S Taylor; Kevan M Shokat
Journal:  Nat Chem Biol       Date:  2007-12       Impact factor: 15.040

5.  The art of the chemical probe.

Authors:  Stephen V Frye
Journal:  Nat Chem Biol       Date:  2010-03       Impact factor: 15.040

6.  Getting pharmaceutical R&D back on target.

Authors:  Mark E Bunnage
Journal:  Nat Chem Biol       Date:  2011-06       Impact factor: 15.040

7.  In situ kinase profiling reveals functionally relevant properties of native kinases.

Authors:  Matthew P Patricelli; Tyzoon K Nomanbhoy; Jiangyue Wu; Heidi Brown; David Zhou; Jianming Zhang; Subadhra Jagannathan; Arwin Aban; Eric Okerberg; Chris Herring; Brian Nordin; Helge Weissig; Qingkai Yang; Jiing-Dwan Lee; Nathanael S Gray; John W Kozarich
Journal:  Chem Biol       Date:  2011-06-24

Review 8.  The subcellular distribution of small molecules: from pharmacokinetics to synthetic biology.

Authors:  Nan Zheng; Hobart Ng Tsai; Xinyuan Zhang; Gus R Rosania
Journal:  Mol Pharm       Date:  2011-08-15       Impact factor: 4.939

9.  Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain.

Authors:  Kay Ahn; Sarah E Smith; Marya B Liimatta; David Beidler; Nalini Sadagopan; David T Dudley; Tim Young; Paul Wren; Yanhua Zhang; Steven Swaney; Keri Van Becelaere; Jacqueline L Blankman; Daniel K Nomura; Shobha N Bhattachar; Cory Stiff; Tyzoon K Nomanbhoy; Eranthie Weerapana; Douglas S Johnson; Benjamin F Cravatt
Journal:  J Pharmacol Exp Ther       Date:  2011-04-19       Impact factor: 4.030

10.  Identification of a novel retinoid by small molecule screening with zebrafish embryos.

Authors:  Chetana Sachidanandan; Jing-Ruey J Yeh; Quinn P Peterson; Randall T Peterson
Journal:  PLoS One       Date:  2008-04-09       Impact factor: 3.240
View more
  108 in total

Review 1.  Recent advances in the molecular design of synthetic vaccines.

Authors:  Lyn H Jones
Journal:  Nat Chem       Date:  2015-12       Impact factor: 24.427

2.  A Role for Widely Interspaced Zinc Finger (WIZ) in Retention of the G9a Methyltransferase on Chromatin.

Authors:  Jeremy M Simon; Joel S Parker; Feng Liu; Scott B Rothbart; Slimane Ait-Si-Ali; Brian D Strahl; Jian Jin; Ian J Davis; Amber L Mosley; Samantha G Pattenden
Journal:  J Biol Chem       Date:  2015-09-03       Impact factor: 5.157

Review 3.  Small Molecule Inhibitors of Protein Arginine Methyltransferases.

Authors:  Hao Hu; Kun Qian; Meng-Chiao Ho; Y George Zheng
Journal:  Expert Opin Investig Drugs       Date:  2016-02-16       Impact factor: 6.206

4.  Synthesis of Dynole 34-2, Dynole 2-24 and Dyngo 4a for investigating dynamin GTPase.

Authors:  Mark J Robertson; Fiona M Deane; Phillip J Robinson; Adam McCluskey
Journal:  Nat Protoc       Date:  2014-03-20       Impact factor: 13.491

5.  Chromodomain Ligand Optimization via Target-Class Directed Combinatorial Repurposing.

Authors:  Kimberly D Barnash; Kelsey N Lamb; Jacob I Stuckey; Jacqueline L Norris; Stephanie H Cholensky; Dmitri B Kireev; Stephen V Frye; Lindsey I James
Journal:  ACS Chem Biol       Date:  2016-07-14       Impact factor: 5.100

Review 6.  Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities.

Authors:  Rachel J Harding; Yu-Feng Tong
Journal:  Acta Pharmacol Sin       Date:  2018-04-05       Impact factor: 6.150

7.  Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID Subunit 1.

Authors:  Junghyun L Suh; Brian Watts; Jacob I Stuckey; Jacqueline L Norris-Drouin; Stephanie H Cholensky; Bradley M Dickson; Yi An; Sebastian Mathea; Eidarus Salah; Stefan Knapp; Abid Khan; Alexander T Adams; Brian D Strahl; Cari A Sagum; Mark T Bedford; Lindsey I James; Dmitri B Kireev; Stephen V Frye
Journal:  Biochemistry       Date:  2018-03-28       Impact factor: 3.162

8.  Design, synthesis, and protein methyltransferase activity of a unique set of constrained amine containing compounds.

Authors:  Hao Zhou; Xin Che; Guochen Bao; Na Wang; Li Peng; Kimberly D Barnash; Stephen V Frye; Lindsey I James; Xu Bai
Journal:  Bioorg Med Chem Lett       Date:  2016-08-03       Impact factor: 2.823

9.  Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637).

Authors:  Alexander M Taylor; Alexandre Côté; Michael C Hewitt; Richard Pastor; Yves Leblanc; Christopher G Nasveschuk; F Anthony Romero; Terry D Crawford; Nico Cantone; Hariharan Jayaram; Jeremy Setser; Jeremy Murray; Maureen H Beresini; Gladys de Leon Boenig; Zhongguo Chen; Andrew R Conery; Richard T Cummings; Leslie A Dakin; E Megan Flynn; Oscar W Huang; Susan Kaufman; Patricia J Keller; James R Kiefer; Tommy Lai; Yingjie Li; Jiangpeng Liao; Wenfeng Liu; Henry Lu; Eneida Pardo; Vickie Tsui; Jian Wang; Yongyun Wang; Zhaowu Xu; Fen Yan; Dong Yu; Laura Zawadzke; Xiaoqin Zhu; Xiaoyu Zhu; Robert J Sims; Andrea G Cochran; Steve Bellon; James E Audia; Steven Magnuson; Brian K Albrecht
Journal:  ACS Med Chem Lett       Date:  2016-03-15       Impact factor: 4.345

10.  CZ415, a Highly Selective mTOR Inhibitor Showing in Vivo Efficacy in a Collagen Induced Arthritis Model.

Authors:  Andrew D Cansfield; Tammy Ladduwahetty; Mihiro Sunose; Katie Ellard; Rosemary Lynch; Anthea L Newton; Ann Lewis; Gavin Bennett; Nico Zinn; Douglas W Thomson; Anne J Rüger; John T Feutrill; Oliver Rausch; Alan P Watt; Giovanna Bergamini
Journal:  ACS Med Chem Lett       Date:  2016-06-10       Impact factor: 4.345
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.